T1D Fund

Massachusetts
cb
Firm Location:Massachusetts • Boston, Massachusetts • Cambridge, Massachusetts
Investor Firms That Co-Invest with T1D Fund
New Enterprise Associates (NEA)Avalon VenturesSamsung VenturesRiverVestDomain AssociatesHatteras Venture PartnersBoehringer Ingelheim Venture FundSanofi VenturesCultivian Sandbox Ventures
T1D Fund Team
Photo of John Ballew, Senior Associate at T1D Fund
John Ballew
T1D Fund·Senior Associate
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA)
Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in Boston / New England (Other Lists)
to see your intro paths to John
Photo of Rachel Cotton, Associate at T1D Fund
Rachel Cotton
T1D Fund·Associate
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA), Investors in Cambridge (MA)
to see your intro paths to Rachel
Photo of Katie Ellias, Managing Partner at T1D Fund
Katie Ellias
T1D Fund·Managing Partner
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in France, Investors in Boston (MA)
Investors in Education (Seed), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed), Investors in Health IT (Seed), Investors in BioTech (Seed), Investors in Medical Devices (Seed), Investors in Pharmaceuticals (Seed), Investors in Education (Seed), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed), Investors in BioTech (Seed), Investors in Health IT (Seed), Investors in Education (Series A), Investors in Medical Devices (Series A), Investors in Pharmaceuticals (Series A), Investors in Digital Health (Series A), Investors in Health IT (Series A), Investors in Health & Hospital Services (Series A), Investors in BioTech (Series A), Investors in Pharmaceuticals (Series A), Investors in Medical Devices (Series A), Investors in Education (Series A), Investors in Digital Health (Series A), Investors in BioTech (Series A), Investors in Health & Hospital Services (Series A), Investors in Health IT (Series A), Investors in Education (Series B), Investors in Medical Devices (Series B), Investors in Pharmaceuticals (Series B), Investors in Digital Health (Series B), Investors in Health IT (Series B), Investors in Medical Devices (Series B), Investors in Health & Hospital Services (Series B), Investors in BioTech (Series B), Investors in Pharmaceuticals (Series B), Investors in Education (Series B), Investors in Digital Health (Series B), Investors in Health & Hospital Services (Series B), Investors in BioTech (Series B), Investors in Health IT (Series B), Investors in Boston / New England (Other Lists)
to see your intro paths to Katie
Photo of Yury Kukushkin, Investor at T1D Fund
Yury Kukushkin
T1D Fund·Investor
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA)
Investors in BioTech (Seed), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in BioTech (Series A), Investors in Boston / New England (Other Lists)
to see your intro paths to Yury
Photo of Amy Montalto, Investor at T1D Fund
Amy Montalto
T1D Fund·Investor
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Providence (RI), Investors in Massachusetts
to see your intro paths to Amy
Photo of Steven St. Peter, Managing Director at T1D Fund
Steven St. Peter
T1D Fund·Managing Director
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA)
to see your intro paths to Steven